RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).
2004-01-01 Mohamed Sorror; Michael Maris; Barry Storer; Brenda Sandmaier; Monic Stuart; Ute Hegenbart; Edward Agura; Thomas Chauncey; Jose Leis; Michael Pulsipher; Peter McSweeney; Jerry Radich; James Wade; Benedetto Bruno; Amelia Langston; Dietger Niederwieser; Karl Blume; Rainer Storb; and David Maloney
NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN
2001-01-01 Sandmaier BM; Maloney DG; Gooley T; Hegenbart U; Shizuru J; Sahebi F; Chauncey T; Agura E; Bruno B; McSweeney P; Forman S; Blume K; Niederwieser D; Strob R
Nonmyeloablative Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT) for the Treatment of Patients (pts) with Poor-Risk, Relapsed or Refractory Multiple Myeloma.
2005-01-01 George E. Georges; Michael B. Maris; David G. Maloney; Brenda M. Sandmaier; Mohamed L. Sorror; Judith A. Shizuru; Dietger W. Niederwieser; Edward D. Agura; Benedetto Bruno; Peter A. McSweeney; Michael A. Pulsipher; Thomas R. Chauncey; Barry E. Storer; and Rainer F. Storb
Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Poor Risk, Relapsed or Refractory Multiple Myeloma.
2004-01-01 George E. Georges; Michael B. Maris; Brenda M. Sandmaier; Judith Shizuru; Dietger W. Niederwieser; Edward Agura; Benedetto Bruno; Peter A. McSweeney8; Rainer F. Storb; and David G. Maloney
ONE-HUNDRED-EIGHT CONSECUTIVE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THE TANDEM AUTO-TBI BASED MINI-ALLO APPROCH
2006-01-01 Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavero P; Giaccone L; Sorasio R; Montefusco V; Busca R; Iori A; Castagna L; Benedetti E; De Fabritiis P; Fanin R; Gallamini A; Corradini P; Levis A; Aglietta M; Pogliani E; Falda M; Petrini M; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced-intensity conditioning in a large cohort of consecutive high-risk patients
2012-01-01 Rambaldi A; Andrea B; Fanin R; Ciceri F; Bonifazi F; Falda M; Lambertenghi-Deliliers G; Benedetti F; Bruno B; Corradini P; Alessandrino P; Iacopino P; Arcese W; Scime R; Raimondi R; Sica S; Todisco E; Lamparelli T; Oneto R; Lombardini L; Pollichieni S; Algarotti A; Carobbio A; Sacchi N; Bosi A
Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors
2010-01-01 Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Georg N. Franke; Ginna G. Laport; Thomas Chauncey; Edward Agura; Michael T. Maris; James Wade; Michael A. Pulsipher; Richard T Maziarz; Firoozeh Sahebi; Peter McSweeney; Benedetto Bruno; Lars indelov; V; Andrew M. Yeager; Andrew Rezvani; Dietger W Niederwieser; Karl G. Blume; Rainer F. Storb; and David G. Maloney
Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).
2007-01-01 Andrew R. Rezvani; L. Norasetthada; T. Gooley; Mohamed Sorror; Stephen J. Forman; Edward Agura; T. Chauncey; Richard T. Maziarz; Michael Maris; J. Shizuru; B. Bruno; James C. Wade; T. Lange; Andrew Yeager; Brenda M. Sandmaier; Rainer F. Storb; and David G. Maloney
Prognostic factors and outcome of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with multiple myeloma relapsed after autografting and rescued with new drugs
2011-01-01 Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P
Prognostic Relevance of "Early-Onset" Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation.
2004-01-01 Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Paul Martin; Razvan Diaconezcu; Brenda Sandmaier; David Maloney; Thomas Chauncey; Michael Maris; Judith Shizuru; Karl Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; and Rainer Storb
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL). | 2004 | Mohamed Sorror; Michael Maris; Barry Storer; Brenda Sandmaier; Monic Stuart; Ute Hegenbart; Edward Agura; Thomas Chauncey; Jose Leis; Michael Pulsipher; Peter McSweeney; Jerry Radich; James Wade; Benedetto Bruno; Amelia Langston; Dietger Niederwieser; Karl Blume; Rainer Storb; and David Maloney | |
NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN | 2001 | Sandmaier BM; Maloney DG; Gooley T; Hegenbart U; Shizuru J; Sahebi F; Chauncey T; Agura E; Bruno B; McSweeney P; Forman S; Blume K; Niederwieser D; Strob R | |
Nonmyeloablative Unrelated Donor (URD) Hematopoietic Cell Transplantation (HCT) for the Treatment of Patients (pts) with Poor-Risk, Relapsed or Refractory Multiple Myeloma. | 2005 | George E. Georges; Michael B. Maris; David G. Maloney; Brenda M. Sandmaier; Mohamed L. Sorror; Judith A. Shizuru; Dietger W. Niederwieser; Edward D. Agura; Benedetto Bruno; Peter A. McSweeney; Michael A. Pulsipher; Thomas R. Chauncey; Barry E. Storer; and Rainer F. Storb | |
Nonmyeloablative Unrelated Donor Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Poor Risk, Relapsed or Refractory Multiple Myeloma. | 2004 | George E. Georges; Michael B. Maris; Brenda M. Sandmaier; Judith Shizuru; Dietger W. Niederwieser; Edward Agura; Benedetto Bruno; Peter A. McSweeney8; Rainer F. Storb; and David G. Maloney | |
ONE-HUNDRED-EIGHT CONSECUTIVE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THE TANDEM AUTO-TBI BASED MINI-ALLO APPROCH | 2006 | Bruno B; Patriarca F; Rotta M; Maloney D; Mordini N; Casini M; Rambaldi A; Carnevale-Schianca F; Allione B; Soglio D; Bavero P; Giaccone L; Sorasio R; Montefusco V; Busca R; Iori A; Castagna L; Benedetti E; De Fabritiis P; Fanin R; Gallamini A; Corradini P; Levis A; Aglietta M; Pogliani E; Falda M; Petrini M; Massaia M; Palumbo A; Sandmaier B; Storb R; Boccadoro M | |
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced-intensity conditioning in a large cohort of consecutive high-risk patients | 2012 | Rambaldi A; Andrea B; Fanin R; Ciceri F; Bonifazi F; Falda M; Lambertenghi-Deliliers G; Benedetti F; Bruno B; Corradini P; Alessandrino P; Iacopino P; Arcese W; Scime R; Raimondi R; Sica S; Todisco E; Lamparelli T; Oneto R; Lombardini L; Pollichieni S; Algarotti A; Carobbio A; Sacchi N; Bosi A | |
Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors | 2010 | Mohamed L. Sorror; Barry Storer; Brenda M. Sandmaier; Georg N. Franke; Ginna G. Laport; Thomas Chauncey; Edward Agura; Michael T. Maris; James Wade; Michael A. Pulsipher; Richard T Maziarz; Firoozeh Sahebi; Peter McSweeney; Benedetto Bruno; Lars indelov; V; Andrew M. Yeager; Andrew Rezvani; Dietger W Niederwieser; Karl G. Blume; Rainer F. Storb; and David G. Maloney | |
Outcomes of Allogeneic Hematopoietic Cell Transplantation (HCT) after Non-Myeloablative Conditioning in Relapsed Diffuse Large B-Cell Lymphoma (DLBCL). | 2007 | Andrew R. Rezvani; L. Norasetthada; T. Gooley; Mohamed Sorror; Stephen J. Forman; Edward Agura; T. Chauncey; Richard T. Maziarz; Michael Maris; J. Shizuru; B. Bruno; James C. Wade; T. Lange; Andrew Yeager; Brenda M. Sandmaier; Rainer F. Storb; and David G. Maloney | |
Prognostic factors and outcome of reduced-intensity conditioning followed by allogeneic stem cell transplantation in patients with multiple myeloma relapsed after autografting and rescued with new drugs | 2011 | Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P | |
Prognostic Relevance of "Early-Onset" Graft-Versus-Host Disease Following Nonmyeloablative Hematopoietic Cell Transplantation. | 2004 | Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Paul Martin; Razvan Diaconezcu; Brenda Sandmaier; David Maloney; Thomas Chauncey; Michael Maris; Judith Shizuru; Karl Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; and Rainer Storb |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 04-CONTRIBUTO IN ATTI DI CONVEGNO 168
- 04-CONTRIBUTO IN ATTI DI CONVEGNO... 168
Data di pubblicazione
- 2010 - 2018 47
- 2000 - 2009 108
- 1994 - 1999 13
Rivista
- BLOOD 84
- HAEMATOLOGICA 35
- BONE MARROW TRANSPLANTATION 34
- BIOLOGY OF BLOOD AND MARROW TRANS... 8
- ANNALS OF ONCOLOGY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
- CURRENT OPINION IN HEMATOLOGY 1
- HLA 1
- JOURNAL OF HEPATOLOGY 1
Lingua
- eng 167
- ita 1
Accesso al fulltext
- no fulltext 158
- open 10